The prognostic value of RASSF1A promoter hypermethylation in non-small cell lung carcinoma: a systematic review and meta-analysis.
about
Epigenetic therapy in gastrointestinal cancer: the right combinationAberrant Methylation of RASSF1A Closely Associated with HNSCC, a Meta-AnalysisA RASSF1A polymorphism restricts p53/p73 activation and associates with poor survival and accelerated age of onset of soft tissue sarcoma.Cdc20: a potential novel therapeutic target for cancer treatmentGene methylation as a powerful biomarker for detection and screening of non-small cell lung cancer in blood.Prognostic value of CD44 expression in non-small cell lung cancer: a systematic reviewBlood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysisThe prognostic role of RASSF1A promoter methylation in breast cancer: a meta-analysis of published data.RASSF1A promoter hypermethylation is a strong biomarker of poor survival in patients with salivary adenoid cystic carcinoma in a Chinese population.The association of RAS association domain family Protein1A (RASSF1A) methylation states and bladder cancer risk: a systematic review and meta-analysis.Clinical significance and role of lymphatic vessel invasion as a major prognostic implication in non-small cell lung cancer: a meta-analysis.The Prognostic Value of p16 Hypermethylation in Cancer: A Meta-Analysis.The prognostic value of phosphorylated AKT expression in non-small cell lung cancer: a meta-analysis.Role of RASSF1A promoter methylation in the pathogenesis of hepatocellular carcinoma: a meta-analysis of 21 cohort studies.Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis.Clinical utility of RASSF1A methylation in human malignancies.Safeguarding genome stability: RASSF1A tumor suppressor regulates BRCA2 at stalled forks.Tumor suppressor genes on frequently deleted chromosome 3p in nasopharyngeal carcinomaRas effector mutant expression suggest a negative regulator inhibits lung tumor formation.Diminished expression of MGMT & RASSF1A genes in gastric cancer in ethnic population of KashmirQuantitative assessment of the relationship between RASSF1A gene promoter methylation and bladder cancer (PRISMA).Extraction and processing of circulating DNA from large sample volumes using methylation on beads for the detection of rare epigenetic events.Prognostic value of CD117 in cancer: a meta-analysis.Roles of the Hippo pathway in lung development and tumorigenesis.RASSF1A-LATS1 signalling stabilizes replication forks by restricting CDK2-mediated phosphorylation of BRCA2.Association Between RASSF1A Promoter Methylation and Testicular Germ Cell Tumor: A Meta-analysis and a Cohort Study.Association of RASSF1A promoter methylation with gastric cancer risk: a meta-analysis.The relationship between RASSF1A promoter methylation and thyroid carcinoma: A meta-analysis of 14 articles and a bioinformatics of 2 databases (PRISMA).
P2860
Q26745709-EB9DC3A7-C23B-4909-B54B-CE0EF66F80DEQ28066140-5889C5DB-FFA6-49D5-8963-8C0A1A062910Q30413809-37580D8B-2AF1-4D3D-9240-343B58CB88D9Q33584460-4B341F9C-4D7C-4EE6-A329-F13EAE77E166Q33761873-37F3B825-49FA-42E0-94E0-BFD8EDE7E2B5Q34028901-361373EF-01BF-44B5-BACF-531BB49156AEQ34110425-C9098292-D833-4683-B41C-A309EACF9EABQ34277400-9530525F-4182-4908-862D-053FED4A596EQ34323619-7BEB3D94-5F13-4E2F-9DFF-BC2B29AA884CQ34471940-E9CB5DD5-CDC8-45BE-AEC7-475F3B09E9D8Q34534484-F6E758D9-67BF-481F-AB6B-0F52A3472BA5Q34785439-05828AFC-48A1-43B6-A4ED-819F0BDD5E53Q35069595-B7465D5A-65D0-400D-9D53-F8E839F41182Q35102439-BE1330B0-DF84-4224-A585-62984989538EQ35558868-E567605D-422E-4891-88DF-97C0D33BC8E6Q35909621-110DC6EB-A422-40F6-B8C7-C535C20ADCEEQ36185758-CBC67D48-A3D7-4511-92A5-6AA372B96DBAQ37183789-60897615-0A39-4773-9E50-BA740DFE8638Q37525082-EC1A41D5-E1FC-44D9-BAA5-5CBC4E468F01Q37525373-40E8B489-0173-4FE5-9DAF-8421EE64A2EEQ37656296-33F15D30-AADA-40F5-8B13-A6792D3F0114Q37658186-EBBA0CB8-AC9B-4A31-8D3B-65A1F17CAD2DQ37676747-7D07B145-4347-4B94-A957-8EB0AE064452Q38341378-6ECD4FFC-23F4-470C-ACAC-FA98D54AF977Q38956821-E36FFC0F-F3F0-474D-91A4-E4A3CEF5262BQ41664037-97A44491-E4BE-4498-939E-28C0369791CCQ44952417-0F7CD23E-5427-4CD0-B1D9-F62C37ECF832Q47098782-D7A5396B-8558-4168-95A6-C7C18EB97E90
P2860
The prognostic value of RASSF1A promoter hypermethylation in non-small cell lung carcinoma: a systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The prognostic value of RASSF1 ...... atic review and meta-analysis.
@en
The prognostic value of RASSF1 ...... atic review and meta-analysis.
@nl
type
label
The prognostic value of RASSF1 ...... atic review and meta-analysis.
@en
The prognostic value of RASSF1 ...... atic review and meta-analysis.
@nl
prefLabel
The prognostic value of RASSF1 ...... atic review and meta-analysis.
@en
The prognostic value of RASSF1 ...... atic review and meta-analysis.
@nl
P2093
P2860
P356
P1433
P1476
The prognostic value of RASSF1 ...... atic review and meta-analysis.
@en
P2093
Baocheng Wang
Jingwang Bi
P2860
P304
P356
10.1093/CARCIN/BGQ266
P407
P577
2010-12-14T00:00:00Z